Trial will not affect NHS budget

摘要

A clinical trial taking place in Scotland, which compares celecoxib with traditional non-steroidal anti-inflammatory drugs, will not result in increased prescribing costs for the NHS. The SCOT trial (standard care versus celecoxib outcome trial) is being led by the University of Dundee and involves 16,000 patients at 400 GP practices. It will examine the drugs' cardiovascular and gastrointestinal safety over a three-year period.